|
KDM4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.153600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.532600E-01 |
| Normal-vs-Stage2 |
9.776600E-01 |
| Normal-vs-Stage3 |
5.248400E-02 |
| Normal-vs-Stage4 |
3.504200E-02 |
| Stage1-vs-Stage2 |
6.525200E-01 |
| Stage1-vs-Stage3 |
3.937700E-02 |
| Stage1-vs-Stage4 |
6.574100E-02 |
| Stage2-vs-Stage3 |
7.177600E-02 |
| Stage2-vs-Stage4 |
5.829700E-02 |
| Stage3-vs-Stage4 |
8.162200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.020800E-01 |
| Normal-vs-AfricanAmerican |
7.111600E-01 |
| Normal-vs-Asian |
7.378600E-01 |
| Caucasian-vs-AfricanAmerican |
2.674600E-01 |
| Caucasian-vs-Asian |
5.489600E-01 |
| AfricanAmerican-vs-Asian |
5.422800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.618400E-01 |
| Normal-vs-Female |
2.914000E-01 |
| Male-vs-Female |
6.715600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.400600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.982800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.148500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.971700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.048200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.192100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.900010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.988430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.213800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.835600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.958600E-03 |
| Classical-VS-Follicular |
7.083800E-02 |
| Classical-VS-Other |
3.390400E-01 |
| Classical-VS-Normal |
8.578400E-01 |
| Tall-VS-Follicular |
7.606500E-02 |
| Tall-VS-Other |
5.566200E-01 |
| Tall-VS-Normal |
3.162900E-03 |
| Follicular-VS-Other |
7.656000E-01 |
| Follicular-VS-Normal |
1.433010E-01 |
| Other-VS-Normal |
2.892400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.366200E-01 |
| Normal-vs-N1 |
4.693700E-02 |
| N0-vs-N1 |
1.089050E-01 |
|
|
